Skip to main content
. 2019 Mar 22;12(3):440–448. doi: 10.14202/vetworld.2019.440-448

Figure-5.

Figure-5

The liver and spleen of normal control (a and b) and nanoparticles of zinc oxide-administrated rats (c and d). (e and f) The liver of chlorpyrifos-administrated rats showing; (e) congestion of central vein (CO), dilatation of hepatic sinusoids (dashed arrow) and (e) and (f) centrilobular (CL) hepatocellular degeneration and necrosis.